These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8932980)

  • 21. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
    Bussolino F; Aglietta M; Sanavio F; Stacchini A; Lauri D; Camussi G
    J Immunol; 1985 Oct; 135(4):2748-53. PubMed ID: 2411812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
    Söling U; Eibl H; Nagel GA; Unger C
    Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
    Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
    J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
    Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
    Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymotrophic effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glicero-3-phosphocholine in the mouse.
    Cardile V; Mudò G; Jiang X; Casella F; Bindoni M; Belluardo N
    Immunopharmacology; 1997 Oct; 37(2-3):199-207. PubMed ID: 9403339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.
    Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of carbamyl-platelet-activating factor to the Raji lymphoblast platelet-activating factor receptor.
    Travers JB; Li Q; Sprecher H; Fertel RH
    Int J Immunopharmacol; 1992 May; 14(4):515-23. PubMed ID: 1325953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
    J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells].
    Muzia GI; Orlov SM; Berdyshev EV; Kulikov VI
    Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.
    Heymans F; Steiner E; Jouquey S; Godfroid JJ
    J Lipid Mediat; 1989; 1(5):303-12. PubMed ID: 2562436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G; Kertscher HP; Till U
    Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
    Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.
    Pei Y; Barber LA; Murphy RC; Johnson CA; Kelley SW; Dy LC; Fertel RH; Nguyen TM; Williams DA; Travers JB
    J Immunol; 1998 Aug; 161(4):1954-61. PubMed ID: 9712066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
    Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor and its methoxy-analogue ET-18-OCH3 stimulate immediate early gene expression in rat astroglial cultures.
    Dell' Albani P; Condorelli DF; Mudò G; Amico C; Bindoni M; Belluardo N
    Neurochem Int; 1993 Jun; 22(6):567-74. PubMed ID: 8513284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor.
    Chandrasekher G; Ma X; Lallier TE; Bazan HE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1422-8. PubMed ID: 11980856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists.
    Sharif NA; Wiernas TK; Howe WE; Griffin BW; Offord EA; Pfeifer AM
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2562-71. PubMed ID: 9856766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.